Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eva Reisinger
Patient-Specific Molecular Alterations Are Associated With Metastatic Clear Cell Renal Cell Cancer Progressing Under Tyrosine Kinase Inhibitor Therapy
Oncotarget
Oncology
Related publications
Comparison of Tyrosine Kinase Inhibitor Versus Mammalian Target of Rapamycin Inhibitor as Second-Line Molecular-Targeted Therapy for Patients With Poor-Risk Metastatic Renal Cell Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology
Personalized Therapy in Renal Cell Carcinoma: Are the Different Tyrosine Kinase Inhibitors the Same for Any Patient?
Expert Review of Precision Medicine and Drug Development
Molecular Medicine
Drug Discovery
Genetics
Pharmacology
Acanthosis Nigricans Associated With Clear-Cell Renal Cell Carcinoma
Autopsy and Case Reports
High Expression of FER Tyrosine Kinase Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
Oncology Letters
Cancer Research
Oncology
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype
Clinical Genitourinary Cancer
Oncology
Urology
Molecular Genetics of Clear-Cell Renal Cell Carcinoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Metastatic Renal Cell Cancer
Cancer Imaging
Nuclear Medicine
Radiology
Ultrasound Technology
Oncology
Radiological
Imaging
Medicine
Systemic Therapy for Metastatic Non–Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions
Hematology/Oncology Clinics of North America
Oncology
Hematology
IKBKB Expression in Clear Cell Renal Cell Carcinoma Is Associated With Tumor Grade and Patient Outcomes
Oncology Reports
Medicine
Cancer Research
Oncology
